Search Results - Sigrun Greil‐Ressler
- Showing 1 - 2 results of 2
-
1
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer by Richard Greil, Sigrun Greil‐Ressler, Lukas Weiß, Charlotte Schönlieb, Teresa Magnes, B Radl, Gordon T. Bolger, Brigitta Vcelar, Peter P. Sordillo
Published 2018Artigo -
2
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer by Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler, Guenther G. Steger, Sigrun Greil‐Ressler, Marija Balić, Dietmar Heck, R. Jakesz, Josef Thaler, Daniel Egle, D. Manfreda, Vesna Bjelic‐Radisic, Ursula Wieder, Christian F. Singer, Elisabeth Melbinger‐Zeinitzer, Ferdinand Haslbauer, P. Sevelda, Harald Trapl, Viktor Wette, Kerstin Wimmer, Simon Peter Gampenrieder, Rupert Bartsch, Stephanie Strobl, Christoph Suppan, Christine Brunner, Christine Deutschmann, Lidija Soelkner, Christian Fesl, Richard Greil
Published 2021Artigo
Search Tools:
Related Subjects
Cancer
Internal medicine
Medicine
Adverse effect
Anastrozole
Aromatase
Aromatase inhibitor
Breast cancer
Clinical endpoint
Confidence interval
Curcumin
Gastroenterology
Gynecology
Hazard ratio
Hemolysis
Hormonal therapy
Oncology
Pharmacodynamics
Pharmacokinetics
Pharmacology
Phases of clinical research
Randomization
Randomized controlled trial
Relative risk
Subgroup analysis
Surgery
Tolerability
Toxicity